Characterization of recombinant extracellular domain of human interleukin-10 receptor (Q34311415)

1 August 2017

Characterization of recombinant extracellular domain of human interleukin-10 receptor (English)

1 reference

1 August 2017

0 references

Tan JC

1

1 reference

1 August 2017

Braun S

2

1 reference

1 August 2017

Rong H

3

1 reference

1 August 2017

DiGiacomo R

4

1 reference

1 August 2017

Dolphin E

5

1 reference

1 August 2017

Baldwin S

6

1 reference

1 August 2017

Narula SK

7

1 reference

1 August 2017

Zavodny PJ

8

1 reference

1 August 2017

Chou CC

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Journal of Biological Chemistry

1 August 2017

1 reference

1 August 2017

270

1 reference

1 August 2017

21

1 reference

1 August 2017

12906-12911

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

1 August 2017

1 reference

Biological properties of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

The role of IL-10 in crossregulation of TH1 and TH2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

A receptor for interleukin 10 is related to interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Molecular cloning and expression of a receptor for human tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Stoichiometry of interaction between interferon gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Structural design and molecular evolution of a cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Biological properties of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

1 Preparation of monoclonal antibodies: Strategies and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.21.12906

21 January 2018

Identifiers

DOI

10.1074/JBC.270.21.12906

1 reference

1 August 2017

1 reference